Baijin Life Science Holdings Limited, an investment holding company, engages in the purchase, processing, design, production, assembly, trading, and wholesale d...
Cross-Sector Data in Hong Kong Signals a Bifurcated Economic Shift
Baijin Life Science publishes 2026 annual report
Baijin Life Science Holdings (SEHK:1466) Stock Loss Reduction Trend Tests Bullish Narratives
Baijin Life Science FY26 net loss widens to HK$42.67 million; revenue falls 34.12% to HK$89.3 million
Baijin Life Science expects FY2026 loss up to HK$43 million
Hong Kong stock movement: BAIJIN LIFE SCI fell 21.28% with no major negative news, speculation arises from capital movement